Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Mattias Ohlsson

Mattias Ohlsson

Professor

Mattias Ohlsson

Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.

Author

  • Mariana Reza
  • Anders Bjartell
  • Mattias Ohlsson
  • Reza Kaboteh
  • Per Wollmer
  • Lars Edenbrandt
  • Elin Trägårdh

Summary, in English

Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognostic value of BSI during androgen deprivation therapy (ADT).

Department/s

  • Nuclear medicine, Malmö
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
  • Urological cancer, Malmö
  • Department of Astronomy and Theoretical Physics
  • Clinical Physiology, Malmö
  • EpiHealth: Epidemiology for Health

Publishing year

2014

Language

English

Publication/Series

EJNMMI Research

Volume

4

Document type

Journal article

Publisher

BioMed Central (BMC)

Topic

  • Radiology, Nuclear Medicine and Medical Imaging

Status

Published

Research group

  • Nuclear medicine, Malmö
  • Urological cancer, Malmö
  • Clinical Physiology, Malmö

ISBN/ISSN/Other

  • ISSN: 2191-219X